SCHEMBL907386

SCHEMBL907386

CC(Cl)[CH]Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1489743 0.70
SCHEMBL2556849 0.67
SCHEMBL7725 0.67
SCHEMBL2472759 0.67
SCHEMBL43615 0.67
SCHEMBL3801740 0.67
SCHEMBL3801746 0.67
SCHEMBL900897 0.67
SCHEMBL44125 0.67
SCHEMBL11288606 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2686441-B1 METHODS AND USES FOR PREDICTING RESPONSE TO ERIBULIN EISAI R&D MAN CO LTD (JP) 2019-05-08 EP disclosed
US-9637795-B2 Methods and compositions for predicting response to eribulin EISAI R&D MANAGEMENT CO., LTD. (JP) 2017-05-02 US disclosed
US-20150361063-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2015-12-17 US disclosed
EP-2787990-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION Brandeis University (US) 2014-10-15 EP disclosed
US-20140288145-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION BRANDEIS UNIVERSITY (US) 2014-09-25 US disclosed
US-20140235707-A1 METHODS AND COMPOSITIONS FOR PREDICTING RESPONSE TO ERIBULIN EISAI R&D MANAGEMENT CO., LTD. (JP) 2014-08-21 US disclosed
EP-2686441-A1 METHODS AND COMPOSITIONS FOR PREDICTING RESPONSE TO ERIBULIN Eisai R&D Management Co., Ltd. (JP) 2014-01-22 EP disclosed
WO-2013085877-A1 TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION BRANDEIS UNIVERSITY (US) 2013-06-13 WO disclosed
CN-103122019-A Compounds useful for treating neurodegenerative disorders SATORI PHARMACEUTICALS INC 2013-05-29 CN disclosed
WO-2013036665-A1 COMPOUNDS FOR USE IN TREATING NEURODEGENERATIVE DISORDERS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO SATORI PHARMACEUTICALS, INC. (US) 2013-03-14 WO disclosed
WO-2005105025-A1 METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING PERIODONTAL DISEASES BOSTON UNIVERSITY (US) 2005-11-10 WO disclosed
US-20050238589-A1 Methods and compositions for preventing or treating periodontal diseases NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-10-27 US disclosed
CN-1216051-C Macrocyclic analogs and methods of use and preparation thereof EISAI CO LTD (JP) 2005-08-24 CN disclosed
EP-1087960-A4 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO LTD (JP) 2004-12-01 EP disclosed
US-6469182-B1 HALICHONDRIN ANALOGS HAVING PHARMACEUTICAL ACTIVITY, SUCH AS ANTICANCER OR ANTIMITOTIC ACTIVITY EISAI CO., LTD. (JP) 2002-10-22 US disclosed
US-6365759-B1 ANTICARCINOGENIC AND ANTIMITOTIC AGENTS; STABLE; MELANOMA; LEUKEMIA; COLON; MAMMARY GLANDS; OVARIES; PROSTATE GLANDS; LUNGS EISAI CO., LTD. (JP) 2002-04-02 US disclosed
CN-1312804-A Macrocyclic analogs and methods of their use and preparation EISAI CO LTD (JP) 2001-09-12 CN disclosed
US-6214865-B1 Macrocyclic analogs and methods of their use and preparation EISAI CO., LTD. (JP) 2001-04-10 US disclosed
EP-1087960-A1 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO., LTD. (JP) 2001-04-04 EP disclosed
WO-1999065894-A1 MACROCYCLIC ANALOGS AND METHODS OF THEIR USE AND PREPARATION EISAI CO., LTD. (JP) 1999-12-23 WO disclosed